CRIS Current Research Information System

MONTAGNANI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.939
AS - Asia 5.113
EU - Europa 3.820
AF - Africa 290
SA - Sud America 241
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.867
SG - Singapore 1.584
VN - Vietnam 1.393
CN - Cina 1.142
GB - Regno Unito 895
IT - Italia 663
DE - Germania 467
SE - Svezia 461
HK - Hong Kong 335
FR - Francia 281
IN - India 227
RU - Federazione Russa 207
UA - Ucraina 206
IE - Irlanda 172
BR - Brasile 154
NL - Olanda 122
JP - Giappone 85
ZA - Sudafrica 84
EE - Estonia 67
CI - Costa d'Avorio 61
KR - Corea 59
CH - Svizzera 54
TG - Togo 54
FI - Finlandia 52
BG - Bulgaria 42
TH - Thailandia 37
PH - Filippine 35
PL - Polonia 34
TR - Turchia 33
CA - Canada 31
BD - Bangladesh 30
NG - Nigeria 30
JO - Giordania 27
SC - Seychelles 27
MX - Messico 25
AR - Argentina 24
EC - Ecuador 21
TW - Taiwan 20
IQ - Iraq 19
AT - Austria 18
BE - Belgio 18
ID - Indonesia 17
ES - Italia 15
GR - Grecia 13
MY - Malesia 13
IR - Iran 12
SA - Arabia Saudita 11
CO - Colombia 9
EG - Egitto 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
PE - Perù 7
PK - Pakistan 7
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
DK - Danimarca 5
TN - Tunisia 5
AO - Angola 4
CL - Cile 4
HN - Honduras 4
LB - Libano 4
RO - Romania 4
UY - Uruguay 4
VE - Venezuela 4
AU - Australia 3
DZ - Algeria 3
KW - Kuwait 3
LT - Lituania 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
CR - Costa Rica 2
ET - Etiopia 2
GH - Ghana 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
GN - Guinea 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
Totale 15.401
Salva come PNG Salva come JPEG
Città #
Singapore 1.117
Southend 782
Fairfield 634
Ashburn 601
Chandler 538
Santa Clara 317
Hong Kong 311
Ho Chi Minh City 273
San Jose 263
Hanoi 231
Houston 228
Dong Ket 219
Princeton 207
Seattle 200
Wilmington 196
Woodbridge 185
Dublin 171
Cambridge 164
Bologna 157
Beijing 150
Boardman 144
Ann Arbor 141
Jacksonville 127
Hefei 106
Lauterbourg 98
New York 90
Los Angeles 87
Nanjing 85
Dallas 84
Westminster 74
Tokyo 70
Buffalo 62
Padova 62
Abidjan 61
Berlin 60
Lomé 54
Saint Petersburg 49
Medford 48
Haiphong 46
Milan 46
Bern 42
Sofia 41
Helsinki 38
Jinan 37
Da Nang 35
Munich 34
Shenyang 32
Seoul 31
Dearborn 30
Guangzhou 30
Abeokuta 29
Changsha 28
Council Bluffs 28
Nanchang 28
Redondo Beach 28
Amman 27
Hebei 27
San Diego 27
Bremen 25
Florence 25
Frankfurt am Main 24
Shanghai 24
São Paulo 23
Turin 23
Biên Hòa 22
Pune 22
Zhengzhou 22
Chicago 21
Hải Dương 21
Redmond 21
Bangkok 19
Orem 19
Des Moines 18
London 18
Mülheim 18
Rome 18
Falkenstein 17
Warsaw 17
Brussels 16
Jiaxing 16
Phoenix 16
Hangzhou 15
Johannesburg 15
Mahé 15
The Dalles 15
Amsterdam 14
San Francisco 14
Tianjin 14
Toronto 14
Xi'an 14
Brooklyn 13
Mountain View 13
Redwood City 13
Taizhou 13
Can Tho 12
Falls Church 12
Norwalk 12
Shenzhen 12
Baghdad 11
Bengaluru 11
Totale 9.827
Salva come PNG Salva come JPEG
Nome #
A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestine. 303
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study 273
Attitudes of Crohn's Disease Patients: Infodemiology Case Study and Sentiment Analysis of Facebook and Twitter Posts 271
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice 263
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect 252
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 244
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 235
Acute Fitz-Hugh-Curtis Syndrome in a Man due to Gonococcal Infection 224
Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse. 222
The future of dual therapy for hepatitis C virus 221
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 218
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 213
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 213
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 212
Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. 209
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption 207
A Patient With Pancreas Divisum, Recurrent Acute Pancreatitis, and Homozygosity for the Cystic Fibrosis Transmembrane Regulator–Associated Protein 5T Allele 206
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 206
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 198
Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi 197
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 197
Alisporivir for the treatment of chronic HCV 196
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. 187
Understanding Crohn's disease patients reaction to infliximab from facebook: A medical perspective 186
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 185
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 185
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 177
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 176
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 176
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 172
Pharmacological modulation of MRP2 in primary biliary cirrhosis 169
Semisynthetic bile acid FXR and TGR5 agonists: Physicochemical properties, pharmacokinetics, and metabolism in the rats 167
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 166
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 162
PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE 161
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 160
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 157
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 156
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 156
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 155
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 155
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 154
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 154
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 154
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 154
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 153
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 151
Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers 150
Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption 149
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 149
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 149
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 149
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 147
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 147
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 145
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 144
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 141
Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. 137
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 137
Bile acids: Physico-chemical properties, function and activity 135
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 133
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 132
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on 129
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy 127
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 125
Malattie colestatiche del fegato. Rapporti tra fegato e gravidanza. In: Cirrosi epatica: epidemiologia, diagnosi e terapia. 124
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 124
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 124
INFEZIONI E INFESTAZIONI DELL’APPARATO DIGERENTE (capitolo 56) 123
Prognostic value of the albumin-bilirubin grade for the prediction of post-hepatectomy liver failure: A systematic review and meta-analysis 123
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 115
Effects of cholesterol 7alpha-hydroxylase promoter polymorphisms on basal promoter activity and feedback regulation of bile acid synthesis 114
Insulin resistance in viral hepatitis B and C and non virus related chronic hepatitis 112
Infezioni, infestazioni, patologia gastroenterologica emergente dall’immigrazione (capitolo 56) 109
Violaceous Papules and Plaques on the Fingers during COVID-19: A Quiz 107
The Diagnosis and Treatment of Acute Cholecystitis: A Comprehensive Narrative Review for a Practical Approach 107
Treatment of acute hepatitis B with high dose lamivudine 104
A comparison of the analytical performance of sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electrospray and matrix-assisted laser desorption/ionization mass spectrometry in the study of the protein extract from bothrops jararaca snake venom 103
FISIOPATOLOGIA GASTRICA 102
New Developments in the Ultrasonography Diagnosis of Gallbladder Diseases 102
Prevalence of different PPAR-alpha gene polymorphisms and haplotypes in gallstone patients. Dig Liv Dis 2005;Vol. 37 Suppl.1:S36. 101
Cholic acid metabolism in human fecal cultures during diet supplementation with Lactobacillus rhamnosus GG 98
Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring 97
Metabolic, nutritional and immunological parameters in healthy volunteers after inulin and saccharose feeding 96
Gastric autoimmune disorders in patients with chronic hepatitis C before, during the after interferon-alpha therapy 87
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid 87
Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial 86
MDR3 mutations in a large cohort of italian women with intrahepatic cholestasis of pregnancy 84
Hepatic uptake and intestinal absorption of bile acids in the rabbit 81
Efficacy of ursodeoxycholic acid in association with α-interferon for chronic hepatitis C in α-interferon non-responder patients 80
Uptake and killing of Leptospira interrogans and Borrelia burgdorferi, spirochetes pathogenic to humans, by reticuloendothelial cells in perfused rat liver 80
Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells 80
Alcolismo e patologie alcool-correlate 80
Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. 79
Bile acid structure and intestinal absorption in the animal model 79
Phagocytosis of Treponema pallidum and reactive oxygen species production by isolated rat Kupffer cells 78
Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification 77
null 75
Specific antibodies reactive with the 22-kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection 66
null 65
Totale 14.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021485 0 0 0 0 0 0 0 0 0 52 46 387
2021/20221.978 157 70 100 109 134 82 39 97 106 124 638 322
2022/20231.991 242 286 124 235 124 161 52 105 337 47 166 112
2023/2024678 34 94 33 119 50 178 30 30 36 26 23 25
2024/20252.195 83 350 183 148 426 89 128 47 46 172 75 448
2025/20264.838 454 391 469 288 767 307 587 124 1.083 368 0 0
Totale 15.683